GH Research PLC GHRS 深 沪
等待开盘 10-18 09:30:00 美东时间
8.00
+0.260
+3.36%
华盛通- 最 高8.01
- 今 开7.77
- 成交量 7.23万股
- 最 低 7.3409
- 昨 收 7.74
- 总市值 4.16亿
- 52周最高 14.99
- 市盈率 静 --
- 换手率 0.14%
- 52周最低 5.05
- 委 比 0.00%
- 总股本 5202.81万
- 历史最高 30.43
- 量 比 1.06
- 振 幅 8.64%
- 历史最低 5.05
- 每 手 1
- 风险率 2.47%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bright Minds rally ends as psychedelic stocks extend volatility
After a nearly 15-fold rise in value in the previous session, shares of Bright Minds Biosciences (NASDAQ:DRUG) fell ~29% on Wednesday as psychedelic drug developers extended their recent volatility in...
10-17 01:55
GH Research Advances Psychedelic TRD Treatment Trials
GH Research (GHRS) has released an update. GH Research is advancing its clinica...
09-20 19:27
Understanding Incomplete Data: A Call for Comprehensive Analyst Reports
TD Cowen analyst Ritu Baral has maintained their bullish stance on GHRS stock, ...
09-07 04:25
GH Research to Connect at Global Healthcare Conference
GH Research (GHRS) has released an update. GH Research PLC, an Ireland-based co...
09-04 05:27
GH Research Appoints Dr. Velichka 'Villy' Valcheva As New Chief Executive Officer
GH Research PLC a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced the promotion of Dr. Velichka "Villy" Valcheva,
09-03 19:25
Medical journal retracts three articles related to MDMA for PTSD
The journal Psychopharmacology on Aug. 10 retracted three articles related to the use of MDMA for PTSD, the day after the U.S. FDA rejected the use of the psychedlic drug for the condition. Scientists...
08-12 23:50
Psychedelic drug developers face setback as ecstasy-based drug rejected by FDA
The U.S. FDA has rejected privately-held Lykos Therapeutics' drug related to the psychedelic MDMA, also known as ecstasy, for PTSD. The issuing of a Complete Response Letter for midomafetamine is not ...
08-10 06:04
GH Research Engages Investors at Upcoming Conferences
GH Research (GHRS) has released an update. GH Research PLC has announced their ...
06-24 20:54
Psychedelic stocks mixed as FDA comments on MDMA therapy
Companies focused on psychedelic medicines indicated a mixed performance on Friday after the U.S. FDA commented on Lykos Therapeutics' marketing application for midomafetamine (MDMA), also known as ec...
05-31 22:43
